📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cancer cell associated glycans as targets for immunotherapy. (2016)

First Author: Vankemmelbeke M

Attributed to: Improving the functional affinity of human anti-glycan monoclonal antibodies (mabs) for cancer therapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/2162402x.2015.1061177

PubMed Identifier: 26942075

Publication URI: http://europepmc.org/abstract/MED/26942075

Type: Journal Article/Review

Volume: 5

Parent Publication: Oncoimmunology

Issue: 1

ISSN: 2162-4011